Identifying the Impact of Centralized Pain on Pain Outcomes after Spinal Cord Stimulator Trials (POST)

Clicks: 10
ID: 329757
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #62 of 73 articles by views in regional anesthesia and pain medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Objective Chronic pain affects over 100 million people in the United States. Central sensitization contributes to many chronic pain syndromes and may reduce the effectiveness of peripherally directed interventions. Although spinal cord stimulation (SCS) is effective for many patients, identifying those less likely to benefit could improve patient selection and reduce unnecessary procedures. We hypothesized that centralized pain features are associated with failure to achieve meaningful analgesia during an SCS trial. Methods Participants completed validated questionnaires before SCS trial implantation and within 48 hours of trial removal. Measures included the Brief Pain Inventory (BPI), Central Sensitization Inventory (CSI), 2016 Fibromyalgia Diagnostic Criteria Survey, PROMIS-29 v2.0, PainDETECT, Perceived Stress Scale, PANAS, Childhood Traumatic Events Scale, CSQ-CAT, and Patient Global Impression of Change (PGIC). Results 67 patients were enrolled; 51 completed follow-up. Mean age was 63.5 years, with 67.2% female participants. Baseline average and worst BPI pain severity scores were 6.4 and 8.6, respectively, and mean fibromyalgianess score was 12.5. Following SCS, average and worst pain severity scores improved significantly (p < 0.001), as did all PROMIS domains (p < 0.001—0.002). Responders (≥50% reduction in worst pain) did not differ demographically from non-responders but had significantly lower fibromyalgianess (p = 0.03), CSI scores (p = 0.02), and presence of widespread pain (p = 0.03). Conclusions Patients with greater centralized pain features experienced less analgesic benefit despite overall improvements in pain and function, supporting our hypothesis that nociplastic pain burden influences SCS response. These findings suggest that pre-procedural pain phenotyping may improve patient selection.
Reference Key
openalex_W7214330558 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Paddison Lowe, Anamika Ratri, Md Robiul Islam Talukder, Jinxiang Hu, Emily Schulze, Miranda Mc Millan, Fatima Asif, Bryan Kwon, Andrea L. Chadwick
Journal regional anesthesia and pain medicine
Year 2026
DOI
10.1093/pm/pnag129
URL
https://doi.org/10.1093/pm/pnag129
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.